Company: MVIS
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001641172-25-022632
Chunk: 91

Company: MICROVISION, INC.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 8
Chunk 91
---
ASED COMPENSATION EXPENSE

    (in thousands) 
    2025  
    2024  
    2025  
    2024 

    Share-based compensation expense 
    Three Months
    Ended  
    Six Months
    Ended 

    June
    30,  
    June
    30, 
  
    (in thousands) 
    2025  
    2024  
    2025  
    2024 
  
    Research and development expense 
    $521  
    $1,252  
    $1,029  
    $2,596 
  
    Sales, marketing, general
    and administrative expense 
     1,409  
     2,101  
     2,822  
     4,500 
  
    Total Share-based compensation
    expense 
    $1,930  
    $3,353  
    $3,851  
    $7,096 

Options
Activity and Positions

The
following table summarizes shares, weighted-average exercise price, weighted-average remaining contractual term, and aggregate intrinsic
value of options outstanding and options exercisable as of June 30, 2025 (in thousands, except per share data):

 SCHEDULE OF OPTIONS ACTIVITY AND POSITIONS 

    Weighted-  

    Weighted-  
    Average  

    Average  
    Remaining  
    Aggregate 
  
    Options 
       
    Exercise  
    Contractual  
    Intrinsic 

    Shares  
    Price  
    Term
    (years)  
    Value 
  
    Outstanding as of June 30, 2025 
     666  
    $1.43  
         3.0  
    $129 

    Exercisable as of June 30, 2025 
     666  
    $1.43  
     3.0  
    $129 

As
of June 30, 2025, there is no unrecognized share-based employee compensation related to stock options.

Restricted
Stock Activity and Positions

The
following table summarizes activity and positions with respect to RSUs and PSUs for the six months ended June 30, 2025 (in thousands,
except per share data):

 SCHEDULE OF ACTIVITY AND POSITIONS WITH RESPECT TO RSUs AND PS